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The ﬁeld of ubiquitylation and deubiquitylation of proteins in molecular physiology is grow-
ing at a rapid rate. Our understanding of molecular physiology of these processes may
become limited by the advancement of technologies that scientists can employ.Therefore,
it is important to approach physiological questions of ubiquitylation and deubiquitylation of
proteins from a multiple methodological direction. Indeed, the role of ubiquitylation and
deubiquitylation of proteins in cellular function has been implicated in the pathophysiol-
ogy of human diseases including cancer, viral diseases, and neurodegenerative disorders.
There aremanymodulators (activators and inhibitors) of ubiquitylation and deubiquitylation.
Therefore, the link is being able to rapidly assess potential modulators of ubiquitylation and
deubiquitylation and determine which speciﬁc modulators play a role(s) within a particular
physiological setting. After the speciﬁcmodulators have been identiﬁed, further experimen-
tation is required to assess the downstream use as potential clinical targets for a particular
disease. The ﬁrst step is to identify the speciﬁc modulators. This perspective highlights a
multi-prong technologies approach that uses three novel technologies (BLAP-tagged pro-
teins, TUBES, and DUB-Chips) that can rapidly identify a number of potential candidates
that modulate ubiquitylation and deubiquitylation of cellular proteins.
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COMBINED TECHNOLOGIES APPROACH FOR
UBIQUITYLATION AND DEUBIQUITYLATION OF PROTEINS
In the current age of molecular epithelial physiology, the strengths
of research and the advances in speciﬁc physiological ﬁelds are
dependent upon innovative researchers who think “outside the
technical square.” In doing so, having the imagination to incor-
porate and modify multiple novel technologies can lead to a
synergistic “research effect”; which brings about new discover-
ies and advances in science. A case in point is the subject of this
Perspective article.
The focus of this Perspective is to highlight the recent paper
by Devor and colleagues (Balut et al., 2011) who combined
three novel technologies to ask the speciﬁc question: What is
the role of ubiquitylation and deubiquitylation in regulating
the post-endocytic trafﬁcking and lysosomal degradation of the
intermediate-conductance, Ca2+-dependent K+ channel, KCa3.1?
The results of the paper by Devor and colleagues are signiﬁ-
cant (described below) and will certainly lead to more research
about KCa3.1 by his group and others. Even more important
than the scope of their novel research ﬁndings, is the intrigu-
ing multi-prong technologies approach used in their paper; which
will, undoubtedly, lead to a signiﬁcant advancement in the ﬁeld of
ubiquitylation/deubiquitylation of cellular and membrane pro-
teins. Additionally, the usefulness and potential of their research
approach will have a broad appeal to many scientists studying cel-
lular proteins in molecular physiology, molecular biochemistry,
and molecular chemistry.
In their paper, Devor and co-workers (Balut et al., 2011) clearly
demonstrated that the trafﬁcking of KCa3.1 from the plasma
membrane of HEK (human embryonic kidney) epithelial cells and
delivery to the lysosome entailed signiﬁcant ubiquitylation of the
channel after endocytosis. Additionally, USP8 (ubiquitin speciﬁc
protease, USP), a deubiquitylating enzyme (DUB), regulated the
rate of degradation of KCa3.1 by deubiquitylating KCa3.1 prior to
delivery to the lysosome. These are novel ﬁndings of the molecu-
lar physiology and trafﬁcking of KCa3.1. Though, the journey to
these ﬁndings was via a series of experiments and intriguing blend
of novel technologies.
Initially, Devor and colleagues used their recently described
novel biotin-ligase acceptor protein (BLAP) tagged KCa3.1 chan-
nel (KCa3.1-BLAP) construct that allows them to quickly label
KCa3.1-BLAP at the plasma membrane with either streptavidin
(for immunoblot experiments) or streptavidin-conjugated ﬂuo-
rophore (Alexa488 for immunoﬂuorescence experiments; Balut
et al., 2010a,b). After which, the “molecular” fate of the chan-
nels can be followed within the cell (Balut et al., 2010a). The
KCa3.1-BLAP technology was used in combination with GST-
tagged tandem ubiquitin binding entities (TUBEs, LifeSensors
Inc., Malvern, PA, USA, www.lifesensors.com), an exciting new
technology, in which the TUBEs function as “molecular traps”;
developed by Rodriguez and colleagues (Hjerpe et al., 2009) for
“capturing” ubiquitylated proteins. Indeed, TUBEs display up to
1000-fold increase in afﬁnity for purifying polyubiquitylated pro-
teins compared to a single ubiquitin binding-associated domain,
are very efﬁcient for puriﬁcation of ubiquitylated proteins from
cell lysates and prevent deubiquitylation and degradation by pro-
teases (Hjerpe et al., 2009; Lopitz-Otsoa et al., 2010; Balut et al.,
2011). For interested readers, Rodriguez and co-workers have
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recently described the procedure for the isolation of ubiquitylated
proteins using TUBEs (Aillet et al., 2012). Additionally, a recent
Commentary highlighted the KCa3.1-BLAP-channel technology
(Hamilton, 2010), based on thework of Ting and colleagues (Chen
et al., 2005;Howarth and Ting, 2008), and described the procedure
of the BLAP-channel technology as a novel immunoﬂuorescent-
based assay to access modulators of endocytosis of proteins (Balut
et al., 2010a).
Therefore, using the BLAP-tagged channels and TUBEs, Devor
and co-workers clearly demonstrated that only low amounts
of KCa3.1-BLAP were ubiquitylated at the membrane, how-
ever, KCa3.1-BLAP was heavily ubiquitylated following endocy-
tosis. Additionally, they used an inhibitor of ubiquitin-activating
enzyme E1 (UBEI-41, Biogenova, Rockville,MD,USA) to demon-
strate that internalization of KCa3.1-BLAP may require ubiquity-
lation of either the channel itself or an adaptor as a signal for the
endocytosis (Balut et al., 2011). Further, to determine if KCa3.1-
BLAP had to be deubiquitylated prior to delivery to the lysosome
for degradation, they employed the general inhibitor of DUBs,
PR-619 (LifeSensors Inc.) and demonstrated that DUBs play an
active role for proper trafﬁcking of KCa3.1 to the lysosome. At
this point in the study, Devor and colleagues asked the logical
question:What was the speciﬁc DUB involved in deubiquitylating
KCa3.1? To answer that question, they would of had to screen for
the effect of DUBs on trafﬁcking of KCa3.1, however, with nearly
100 DUBs with the speciﬁcity for ubiquitin in ﬁve gene families in
the human genome (Reyes-Turcu et al., 2009), a systematic “one-
by-one” experimental screening approach would not have been an
experimentally viable or cost–effective option.
Enter in the next novel methodology used by Devor and col-
leagues in their paper. One of the authors (CML) was developing a
DUB-Chip,aDUB-proteinmicroarray (LifeSensors Inc.), inwhich
35 enzymatically active DUBs, as well as, several deSUMOylases
and deNeddylases, are impregnated in triplicate at three separate
concentrations on the protein microarray (Loch et al., 2011). This
novel methodology, allows the direct enzymatic activity between
soluble polypeptide substrates and the impregnated DUBs (Loch
et al., 2011). Additionally, the DUB-Chip approach reduces the
labor-intensive efforts and costs of overexpression, knockdown,
yeast two-hybrid, or pull-down experiments when screening for
potentialDUBs involved indeubiquitylationprocesses (Balut et al.,
2011). Additionally, with a protein microarray format, a number
of potential DUBs can be identiﬁed which could lead to further
research projects.
So, the third novel methodology used by Devor and co-workers
(Balut et al., 2011) was the DUB-Chip protein microarray and
this was used in combination with the BLAP-tagged channels
labeled with streptavidin–Alexa488 and the TUBEs to address the
question of the which DUB(s) was (were) involved in the deubiq-
uitylation of KCa3.1 during trafﬁcking to the lysosome? Brieﬂy,
KCa3.1-BLAP channels were transfected into HEK cells and the
channels were enzymatically biotinylated and streptavidin labeled
at the plasma membrane and cells were then immediately lysed
in the presence of GST-TUBE2 (time= 0), or returned to 37˚C
for various periods of time (90min or 3 h) to allow endocyto-
sis and then lysed in the presence of TUBEs (Balut et al., 2011).
The TUBEs with their ubiquitylated proteins were pulled down
on glutathione agarose, eluted, and then directly hybridized to the
DUB-Chip. Since the only ﬂuorescent protein in the sample was
KCa3.1, an association of the channel with a DUB on the protein
microarray could be evaluated by scanning arrays with a Typhoon
Imager (9410 Imager, GE Life Sciences, Piscataway, NJ, USA; Balut
et al., 2011). Channel-DUB interactions were veriﬁed after 90min
as there were notable interactions of KCa3.1 with USP2 and USP8
and a weaker association with AMSH (associated molecule with
the SH3 domain of STAM; Figure 1). However, it was noted that
these associations were transient in nature, as samples collected
at 3 hr did not exhibit any association of KCa3.1 with the DUBs
(Balut et al., 2011). Therefore, KCa3.1 is the ﬁrst protein to be
used to demonstrate a direct interaction between any protein and
a DUB on the DUB-Chip protein microarray.
Finally, Devor and co-workers (Balut et al., 2011) chose to pur-
sueUSP8 because thatDUBhad been reported in deubiquitylating
proteins targeted to the lysosome for degradation (Alwan and van
Leeuwen, 2007). After which, they used USP8 overexpression and
knockdown experiments to unequivocally demonstrate that USP8
was imperative for proper deubiquitylation of KCa3.1 and delivery
of KCa3.1 to the lysosome for degradation (Balut et al., 2011).
ADVANTAGES AND DISADVANTAGES OF THE COMBINED
NOVEL TECHNOLOGY APPROACH?
There are many advantages to the multi-prong technologies
approach which Devor and colleagues (Balut et al., 2011) utilized
in their paper. (1) The use of the combination of BLAP-tagged
channels and the TUBEs greatly reduced the total amount of time
(and cost of reagents) to examine the ubiquitylation of proteins
versus exercising a random cell surface biotinylation followed by
streptavidin pull-down and subsequent immunoprecipitation fol-
lowedby an immunoblot for ubiquitin. (2)This combinedmethod
is more sensitive and requires only 500μg of total protein of inter-
est (e.g., KCa3.1) to detect the ubiquitylated membrane-bound
protein as compared to 2–3mg with the traditional approach. (3)
The use of TUBEs allows the isolation (and puriﬁcation depend-
ing upon the project) of ubiquitylated proteins from cell lysates
while preventing the action of proteases. (4) When using the
DUB-Chip, one increases the chance to detect multiple DUBs
that might associate with the protein (e.g., channel) of interest.
This would increase the potential interacting partners for fur-
ther investigation. For example, Devor and colleagues alluded to
their further study with USP2. Finally, (5) in their summary para-
graph, Devor provides the research potential of their multi-prong
technologies approach by suggesting that they anticipate DUB-
protein associations in additional cellular compartments will be
adaptable to their experimental paradigm using a wide range of
epitope tags.
Of course, novel technologies have their price. The costs of
an overall study depends upon a number of factors including the
costs of personnel and reagents, but one still has to remember
the number of procedures/protocols that are used to obtain the
research results. It is not surprising that the costs of the TUBEs
and DUB-Chip are considerable, however, the experimental para-
digm described by Devor and co-workers (Balut et al., 2011) will
certainly reduce the number of experimental procedures neces-
sary to obtain a result, and has the potential of identifying new
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FIGURE 1 | DUB-Chip as a tool for identifying DUBs interacting with
KCa3.1. (A) Immunoﬂuorescence images of BLAP-KCa3.1 labeled with
streptavidin–Alexa488 and incubated for 0, 90min, or 3 h at 37˚C. (B)
Cells were lysed in the presence of GST-TUBE2, then the lysates were
pulled down on GST beads, eluted and hybridized on a DUB panel.
Interactions between the ﬂuorescently tagged KCa3.1 and speciﬁc
DUBs were quantiﬁed by measuring ﬂuorescence intensity. (C) Dub-Chip
data, expressed as relative ﬂuorescence units (RFU), indicated that there
were interactions between ubiquitylated KCa3.1 and ubiquitin speciﬁc
protease 2 (UPS2), UPS 8 and a weaker interaction with AMSH
[associated molecule with the SH3 domain of STAM; highlighted in red in
(C)]. As can be seen, the interactions between the ubiquitylated KCa3.1
and the DUBs were transient, as interactions were not identiﬁed at
180min. (D)This panel lists the various classes of DUBs,
DeSUMOylases, and deNEDDylases impregnated on the DUB-Chip. This
ﬁgure was used with permission from FASEB J. The ﬁgure legend was
slightly modiﬁed from the original Figure 4A and 4B from Balut et al.
(2011).
protein-protein interactions for further study. So, at the end of
the experimental day, the overall ﬁndings and potential research
advances that might be unearthed would certainly out-weigh the
costs of some reagents.
CLINICAL AND THERAPEUTIC ASPECTS?
Ubiquitylation and deubiquitylation of proteins are processes
that regulate protein recycling and degradation in all cells. So,
DUBs play major roles in cellular protein turnover. Therefore, it
is not surprising that modulators of DUBs have been touted as
potential targets for therapeutic treatment of a number of dis-
eases including cancer (Colland, 2010). In fact, USPs are promis-
ing molecules for pharmacological modulation in the ubiquitin
regulatory machinery (Daviet and Colland, 2008). Our under-
standing of the molecular physiology of ubiquitylation and deu-
biquitylation of ion transport proteins is just at the “edge” of
an explosion of research. Therefore, the experimental paradigm
that Devor and co-workers (Balut et al., 2011) have provided in
their paper can be the experimental “road-map” that can be used
by others to explore the interactions of other DUBs and other
www.frontiersin.org May 2012 | Volume 3 | Article 137 | 3
Hamilton BLAP-tag, TUBEs and DUB-Chips
ion transport proteins, of which, some may be responsible for
disease.
FINAL THOUGHTS
The blending of these three novel technologies,presented byDevor
and co-workers (Balut et al., 2011), has the synergetic potential
for application in a plethora of cell types. Hence, the experimen-
tal paradigm of this multi-prong approach will certainly advance
our efforts in understanding the ubiquitylation/deubiquitylation
processes of cellular andmembrane proteins. Further, the future of
modulation of DUBs being developed as a potential clinical appli-
cation appears to be ever so close these days.We,molecular epithe-
lial physiologists, must ‘push’ ourselves and relish the opportunity
that this multi-prong technologies approach offers us. Undoubt-
edly, Devor and co-workers are forging forward with this exciting
experimental paradigm to tackle ubiquitylation/deubiquitylation
of KCa3.1 channels in a polarized epithelium. Other molecular
epithelial physiologists must follow.
My ﬁnal thought is to ﬁrmly agree with the last sentence in the
Devor paper. “Given the critical role that DUBs play in a host of
physiological processes, the ability to rapidly screen protein-DUB
interactions from cell lysates represents an important advance in
the ubiquitin ﬁeld.”
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